← Leaderboards
Mirella Salvatore
Weill Medical Coll Of Cornell Univ
$1,417,491
Attributed
$1,417,491
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $296.6K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,417,491 · 3
By mechanism
R21$1,417,491 · 3
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Robert E Schwartz$8,769,705
- James C Lo$6,965,639
- Jiwon Kim$4,201,792
- Shelli Farhadian$5,545,336
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirus DiseasesInfectionCellsImmunityInterestInfluenza A Virus NucleoproteinInterphase CellImmunizationImmune ResponseInfluenzaInfluenza A VirusBaseIntegraseImmunologicsBody Weight DecreasedAntibodiesEffectivenessCellular TransductionImmune SystemCell Culture TechniquesAntigensCharacteristicsGenes
Grant awards (6)
The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19$169,500
R21 · FY2025 · AI · contact PI
The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19$296,625
R21 · FY2024 · AI · contact PI
Integrase Defective Lentiviral Vectors for Antibody Delivery against Influenza$254,250
R21 · FY2017 · AI · contact PI
Integrase Defective Lentiviral Vectors for Antibody Delivery against Influenza$211,875
R21 · FY2016 · AI · contact PI
Integrase-defective lentiviral based influenza vaccines$222,363
R21 · FY2010 · AI · contact PI
Integrase-defective lentiviral based influenza vaccines$262,878
R21 · FY2009 · AI · contact PI